Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
- 16 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Obesity
- Vol. 36 (6), 880-885
- https://doi.org/10.1038/ijo.2011.165
Abstract
International Journal of Obesity is a monthly, multi-disciplinary forum for papers describing basic, clinical and applied studies in biochemistry, genetics and nutrition, together with molecular, metabolic, psychological and epidemiological aspects of obesity and related disordersKeywords
This publication has 28 references indexed in Scilit:
- Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy ExpenditureJournal of Clinical Endocrinology & Metabolism, 2011
- Gender, Age, Body Mass Index, and IGF-I Individually and Jointly Determine Distinct GH Dynamics: Analyses in One Hundred Healthy AdultsJournal of Clinical Endocrinology & Metabolism, 2011
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesityJCI Insight, 2010
- Peripheral CNR1 antagonists to the foreScience-Business eXchange, 2010
- Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feedingBritish Journal of Pharmacology, 2009
- The role of peptide YY in appetite regulation and obesityThe Journal of Physiology, 2009
- Co‐administration of SR141716 with peptide YY3–36 or oxyntomodulin has additive effects on food intake in miceDiabetes, Obesity and Metabolism, 2007
- Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese menInternational Journal of Obesity, 2007
- Central nervous system control of food intake and body weightNature, 2006
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003